Weighted average basic and diluted number of common shares outstanding |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average basic and diluted number of common shares outstanding [Text Block] |
20. Weighted average basic and diluted number of common shares outstanding
Diluted weighted average number of common shares for the years ended December 31, 2025 excludes nil anti-dilutive preferred shares (2024: nil), 7,762,340 anti-dilutive stock options (2024: 8,044,000) and 7,160,440 anti-dilutive warrants (2024: 14,089,280). |